SNOA (Sonoma Pharmaceuticals) Cyclically Adjusted Book per Share: $233.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNOA Sonoma Pharmaceuticals Inc SNOA
45 GF Score
Price $1.33
GF Value $1.52
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Sonoma Pharmaceuticals Cyclically Adjusted Book per Share?

Sonoma Pharmaceuticals SNOA 45 Cyclically Adjusted Book per Share is $233.08 as of Jun. 2026. GuruFocus rates SNOA with a GF Score™ of 45/100 and a GF Value™ of $1.52 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sonoma Pharmaceuticals's adjusted book value per share for the three months ended in Jun. 2026 was $1.378. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $233.08 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Sonoma Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -19.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -21.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -12.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sonoma Pharmaceuticals was -1.20% per year. The lowest was -26.10% per year. And the median was -15.40% per year.

As of today (2026-09-09), Sonoma Pharmaceuticals's current stock price is $1.33. Sonoma Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $233.08. Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sonoma Pharmaceuticals was 1.36. The lowest was 0.01. And the median was 0.18.


Sonoma Pharmaceuticals  (NAS:SNOA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.33/233.08
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sonoma Pharmaceuticals was 1.36. The lowest was 0.01. And the median was 0.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sonoma Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Sonoma Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sonoma Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonoma Pharmaceuticals Cyclically Adjusted Book per Share Chart

Sonoma Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 506.60 501.02 441.76 307.17 241.98

Sonoma Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 287.75 269.43 252.42 241.98 233.08

SNOA vs GELS, APUS, BTAI: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


SNOA
45GF Score
Sonoma Pharmaceuticals Inc SNOA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sonoma Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sonoma Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.378/333.9520*333.9520
=1.378

Current CPI (Jun. 2026) = 333.9520.

Sonoma Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201609 262.565 241.428 363.189
201612 952.625 241.432 1,317.684
201703 892.958 243.801 1,223.150
201706 775.250 244.955 1,056.914
201709 673.333 246.819 911.036
201712 548.308 246.524 742.762
201803 450.765 249.554 603.212
201806 350.806 251.989 464.911
201809 299.583 252.439 396.319
201812 199.104 251.233 264.659
201903 158.924 254.202 208.783
201906 174.303 256.143 227.251
201909 155.621 256.759 202.407
201912 125.944 256.974 163.671
202003 63.191 258.115 81.757
202006 116.429 257.797 150.823
202009 113.353 260.280 145.437
202012 118.423 260.474 151.829
202103 51.076 264.877 64.396
202106 44.010 271.696 54.094
202109 76.400 274.310 93.011
202112 72.058 278.802 86.312
202203 56.110 287.504 65.175
202206 51.348 296.311 57.871
202209 45.297 296.808 50.966
202212 35.865 296.797 40.355
202303 32.296 301.836 35.732
202306 28.179 305.109 30.843
202309 21.911 307.789 23.774
202312 9.784 306.746 10.652
202403 7.868 312.332 8.413
202406 5.237 314.175 5.567
202409 3.997 315.301 4.233
202412 3.014 315.605 3.189
202503 2.700 319.799 2.819
202506 2.469 322.561 2.556
202509 2.295 324.800 2.360
202512 1.983 324.054 2.044
202603 1.720 330.213 1.739
202606 1.378 333.952 1.378

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $233.08 mean?
Sonoma Pharmaceuticals (SNOA) has a Cyclically Adjusted Book per Share of $233.08 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sonoma Pharmaceuticals and its competitors.
Is Sonoma Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Sonoma Pharmaceuticals' current Cyclically Adjusted Book per Share is $233.08. Overall, Sonoma Pharmaceuticals has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonoma Pharmaceuticals' Cyclically Adjusted Book per Share compare to GELS and APUS?
Sonoma Pharmaceuticals' Cyclically Adjusted Book per Share of $233.08 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sonoma Pharmaceuticals and its competitors. Sonoma Pharmaceuticals's current Cyclically Adjusted Book per Share is $233.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonoma Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sonoma Pharmaceuticals (SNOA) is currently considered Modestly Undervalued. The stock's GF Value™ is $1.52, compared to a current price of $1.33 — trading 12.5% below its estimated fair value. The current Cyclically Adjusted Book per Share is $233.08. Sonoma Pharmaceuticals' overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sonoma Pharmaceuticals (SNOA), the current Cyclically Adjusted Book per Share is $233.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonoma Pharmaceuticals (SNOA) Overvalued in 2026?

Based on GuruFocus' analysis, Sonoma Pharmaceuticals stock appears to be undervalued. The current stock price of $1.33 is trading 12.5% below its estimated GF Value™ of $1.52. GuruFocus considers Sonoma Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for SNOA:

  • Cyclically Adjusted Book per Share: $233.08
  • GF Value™: $1.52 vs. price of $1.33 (12.5% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the SNOA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sonoma Pharmaceuticals Business Description

Address 5445 Conestoga Court, Suite 150, Boulder, CO, USA, 80301
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
45GF Score

Get the complete analysis for SNOA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.33
Price
$1.52
GF Value